Denali Therapeutics
Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families.
Org chart
Teams
View all
Discover similar companies
ONI
Series B • San Diego, United States
Voyager Therapeutics
Series B • Cambridge, United States
Travere Therapeutics
Post IPO Debt • San Diego, United States
Hubilo
Series B • San Francisco, United States
Arcus Biosciences
Post IPO Equity • Hayward, United States
Neuralink
Secondary Market • Fremont, United States
RippleMatch
Series B • New York, United States
Favor
Series B • San Mateo, United States
Harbour BioMed
Series C • Cambridge, United States
Surest
Series B • Minneapolis, United States
Sherlock Biosciences
Series B • Boston, United States
Editas Medicine
Post IPO Equity • Cambridge, United States
helps you hire
great candidates
It’s free to use - try it out today.